Research ArticleClinical Studies

Eruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer

ALBERTO MENEGUZZO, ANNALISA LAZZAROTTO and MAURO ALAIBAC
In Vivo January 2020, 34 (1) 441-445; DOI: https://doi.org/10.21873/invivo.11793

Article Information

vol. 34 no. 1 441-445
DOI 
https://doi.org/10.21873/invivo.11793
PMID 
31882511
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received August 29, 2019
  • Revision received September 27, 2019
  • Accepted September 30, 2019
  • Published online December 27, 2019.
Copyright & License 
Copyright © 2020 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. ALBERTO MENEGUZZO,
  2. ANNALISA LAZZAROTTO and
  3. MAURO ALAIBAC⇑
  1. Unit of Dermatology, University of Padua, Padua, Italy
  1. Correspondence to: Mauro Alaibac, Unit of Dermatology, University of Padua, via Gallucci 4, 35128 Padua, Italy. Tel: +39 0498212901, e-mail: mauro.alaibac{at}unipd.it
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Eruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer
ALBERTO MENEGUZZO, ANNALISA LAZZAROTTO, MAURO ALAIBAC
In Vivo Jan 2020, 34 (1) 441-445; DOI: 10.21873/invivo.11793
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords